SCHEMBL1274448

SCHEMBL1274448

N#CC(=CCCc1ccccc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.49
LMNA P02545 2/20 0.44
PLIN1 O60240 1/20 0.44
PLIN5 Q00G26 1/20 0.44
ABHD5 Q8WTS1 1/20 0.44
GPR52 Q9Y2T5 2/20 0.44
KDM4E B2RXH2 4/20 0.42
PKM P14618 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
EGFR P00533 2/20 0.42
CYP3A4 P08684 2/20 0.42
HPGD P15428 2/20 0.42
MEN1 O00255 1/20 0.42
RGS12 O14924 1/20 0.42
GMNN O75496 1/20 0.42
ERBB2 P04626 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1275333 0.82 LMNA (0.46) LMNAPLIN1PLIN5ABHD5KDM4E
SCHEMBL28322438 0.82 BCL2A1 (0.43)
SCHEMBL8479312 0.82 GPR52 (0.46) LMNAGPR52KDM4EPKMKMT2A
SCHEMBL8479309 0.82 GPR52 (0.46) LMNAGPR52KDM4EPKMKMT2A
SCHEMBL9901355 0.78 GRIK1 (0.42) GRIK1GPR52ALDH1A1HPGDCYP1A2
SCHEMBL9286665 0.78 MCL1 (0.51) LMNAPLIN1PLIN5ABHD5KDM4E
SCHEMBL8218335 0.76 GRIK1 (0.56) GRIK1GPR52ALDH1A1MAPK1SMN1; SMN2
SCHEMBL22607727 0.76 GRIK1 (0.56) GRIK1GPR52ALDH1A1MAPK1SMN1; SMN2
SCHEMBL10952837 0.76 ALDH1A1 (0.48) LMNAPLIN1PLIN5ABHD5KDM4E
SCHEMBL10952830 0.76 ALDH1A1 (0.48) LMNAPLIN1PLIN5ABHD5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9752049-B2 Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same UT-BATTELLE, LLC (US) 2017-09-05 US claimed
EP-2852645-B1 A CURABLE COMPOSITION COMPRISING CYANOACRYLATE MONOMERS HENKEL AG & CO KGAA (DE) 2016-04-13 EP claimed
US-20150232690-A1 OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME UT-BATTELLE, LLC (US) 2015-08-20 US claimed
EP-1360257-B1 CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS LOCTITE R & D LTD (IE) 2007-07-25 EP claimed
US-6977278-B1 Cyanoacrylate compositions curable to flexible polymeric materials LOCTITE (R&D) LTD. (IE) 2005-12-20 US claimed
WO-2004089276-A2 THIAZOLIDINEDIONE COMPOUNDS WITH HYPOGLYCEMIC PROPERTIES CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ (BR) 2004-10-21 WO claimed
WO-2004024467-A2 SURFACE-MOUNTING SYSTEM LOCTITE (R & D) LIMITED (IE) 2004-03-25 WO claimed
US-20250304529-A1 BIOBASED CYANOACRYLATE COMPOUND BOSTIK SA (FR) 2025-10-02 US disclosed
EP-4532465-A1 BIOBASED CYANOACRYLATE COMPOUND Bostik SA (FR) 2025-04-09 EP disclosed
WO-2023232948-A1 BIOBASED CYANOACRYLATE COMPOUND BOSTIK SA (FR) 2023-12-07 WO disclosed
EP-4286369-A1 BIOBASED CYANOACRYLATE COMPOUND Bostik SA (FR) 2023-12-06 EP disclosed
CN-114126838-A 3D printing method and system 波士胶公司 2022-03-01 CN disclosed
EP-3947586-A1 FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2022-02-09 EP disclosed
EP-1951831-A1 ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER Henkel AG & Co. KGaA (DE) 2008-08-06 EP disclosed
EP-1945702-A1 ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER Henkel AG & Co. KGaA (DE) 2008-07-23 EP disclosed
WO-2007054113-A1 ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER HENKEL AG & CO. KGAA (DE) 2007-05-18 WO disclosed
WO-2007054112-A1 ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER HENKEL AG & CO. KGAA (DE) 2007-05-18 WO disclosed
US-6977278-B1 Cyanoacrylate compositions curable to flexible polymeric materials LOCTITE (R&D) LTD. (IE) 2005-12-20 US disclosed
WO-2004089276-A2 THIAZOLIDINEDIONE COMPOUNDS WITH HYPOGLYCEMIC PROPERTIES CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ (BR) 2004-10-21 WO disclosed
WO-2004024467-A2 SURFACE-MOUNTING SYSTEM LOCTITE (R & D) LIMITED (IE) 2004-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304529-A1 BIOBASED CYANOACRYLATE COMPOUND BAP1, CBR1, CBR3 GRIK1 3885/4885LMNA 992/4885PLIN1 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.